Literature DB >> 1318201

A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.

A Guimezanes1, T N Schumacher, H L Ploegh, A M Schmitt-Verhulst.   

Abstract

Alloreactive class I-restricted T cells may recognize the class I structure alone, in association with a specific peptide, or with any stabilizing peptide. We have tested the role of endogenous peptides in the recognition of H-2Kb molecules by two alloreactive cytolytic T lymphocyte (CTL) clones using the mutant tumor line RMA-S, which expresses its surface H-2b molecules devoid of peptides and is not lysed by these two CTL clones. Empty H-2b molecules on RMA-S cells can be stabilized by binding exogenously added peptides. H-2Kb-specific recognition of the RMA-S cells by one of the CTL clones was restored by endogenous peptide extracts which only minimally stabilized H-2Kb on the surface of RMA-S cells, indicating the requirement for a specific peptide on a limited number of H-2Kb molecules. In addition, one out of three peptides which greatly enhance the expression of H-2Kb, the nucleoprotein peptide 52-59 from vesicular stomatitis virus (VSV), was also able to restore the lysis of RMA-S cells by the clone. The recognition of a common motif by an alloreactive clone (H-2k anti-H-2Kb) and virus-specific Kb-restricted clones suggests that both H-2k and H-2b thymic environments allow selection of T cells capable of recognizing H-2Kb+VSV and that tolerance to self, as would be the case in the (H-2k x H-2b)F1 mice, would partially delete the repertoire of antiviral T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318201     DOI: 10.1002/eji.1830220647

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain.

Authors:  D Housset; G Mazza; C Grégoire; C Piras; B Malissen; J C Fontecilla-Camps
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

2.  A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.

Authors:  J Dal Porto; T E Johansen; B Catipović; D J Parfiit; D Tuveson; U Gether; S Kozlowski; D T Fearon; J P Schneck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

3.  Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides.

Authors:  L A Sherman; S Chattopadhyay; J A Biggs; R F Dick; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

4.  Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition.

Authors:  J A Bluestone; S Jameson; S Miller; R Dick
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

5.  Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity.

Authors:  S Chattopadhyay; M Theobald; J Biggs; L A Sherman
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

6.  Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL).

Authors:  P A Smith; A Brunmark; M R Jackson; T A Potter
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.